Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06564948 · ClinicalTrials.gov registry record · NA
Treatment for Individuals Interacting with the Criminal Justice System
A NA study of Suicide Risk and Psychiatric Disorders, sponsored by Cambridge Health Alliance.
- Recruiting
- Registry status
- NA
- Development phase
- 1,040
- Enrollment target
- 1
- Study location
NCT06564948: Recruiting NA study of Suicide Risk and Psychiatric Disorders, sponsored by Cambridge Health Alliance.
NCT06564948 is a NA study of Suicide Risk and Psychiatric Disorders that is actively recruiting participants, run by Cambridge Health Alliance. The registered enrollment target is 1,040 participants, above the 884-participant average among 4 other Suicide Risk trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06564948, a NA study of Suicide Risk and Psychiatric Disorders, is actively recruiting participants, sponsored by Cambridge Health Alliance.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,040 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed Center will leverage burgeoning real-time data linkage capabilities among health systems, Medicaid payors, and criminal legal (e.g., jail booking data, jail release data) systems, to identify individuals coming in and out of jail for suicide assessment and prevention, and to better coordinate care across these disparate systems. This Center will advance the fields of suicide prevention and criminal legal system-based mental health by solving a well-known, central problem in both fields: the inability to track and intervene with individuals moving in and out of both and often multiple systems. The goal is near-term reductions in the U.S. suicide rate.
Primary Outcome
Number of participants with a past-year medically treated suicide attempt. This will be measured at baseline and 12 months will be collected using the electronic health record (EHR) data.
Conditions Studied
Interventions
- OTHER Treatment as usual (TAU)
- OTHER Family and Social Justice
- OTHER Family and Social Justice Service and Navigator (FSJS+Navigator) Intervention
Study Locations (1)
Massachusetts
- Cambridge Health Alliance - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,040 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT06564948 shows while recruiting
NCT06564948 is an interventional study that assigns participants to a tested intervention. Its 1,040 participants enrollment target places it among the larger protocols in the corpus, above the 884-participant average among 4 other Suicide Risk trials with a reported enrollment target (18% higher).
The record links to 2 conditions, with Suicide Risk appearing as the primary indexed condition, and to 3 interventions - of which Treatment as usual (TAU) is the first listed.
NCT06564948 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06564948 about?
NCT06564948 is a clinical study titled "Treatment for Individuals Interacting with the Criminal Justice System". The proposed Center will leverage burgeoning real-time data linkage capabilities among health systems, Medicaid payors, and criminal legal (e.g., jail booking data, jail release data) systems, to identify individuals coming in and out of jail for suicide assessment and prevention, and to better coor...
What is the current status of trial NCT06564948?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,040 participants. The study started on 2025-02-01. Estimated completion is 2027-09-30.
What conditions does trial NCT06564948 study?
This clinical trial studies the following conditions: Suicide Risk, Psychiatric Disorders.
What interventions are being tested in trial NCT06564948?
The interventions under investigation include: Treatment as usual (TAU) (OTHER), Family and Social Justice (OTHER), Family and Social Justice Service and Navigator (FSJS+Navigator) Intervention (OTHER).
Who is sponsoring clinical trial NCT06564948?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06564948 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide Risk
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Get Better Together: Relationship Education For Military Couples
RECRUITING · NA
-
Long-term Observation of Participants With Mood Disorders
RECRUITING
-
Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical Trial
RECRUITING · Phase 2
-
Efficient, Holistic, Heuristic and Semi-structured Suicide Assessment Tool (EHSSA) - Very Accurate Prediction of Risk.
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05219110 · 1,040 participants · NA
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
- NCT06661720 · 1,040 participants · Phase 3
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- NCT04685616 · 1,042 participants · Phase 3
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
- NCT07345767 · 1,038 participants · NA
Hypknowledge Nationwide Sleep Extension
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI